nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Hydroxyurea—head and neck cancer	0.296	0.567	CbGbCtD
Rivastigmine—CYP2D6—Vinblastine—head and neck cancer	0.105	0.201	CbGbCtD
Rivastigmine—CYP3A4—Vinblastine—head and neck cancer	0.0667	0.128	CbGbCtD
Rivastigmine—CYP3A4—Docetaxel—head and neck cancer	0.055	0.105	CbGbCtD
Rivastigmine—Osteoarthritis—Fluorouracil—head and neck cancer	0.0016	0.00335	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.0016	0.00335	CcSEcCtD
Rivastigmine—Pulmonary embolism—Docetaxel—head and neck cancer	0.00159	0.00333	CcSEcCtD
Rivastigmine—Phosphatase alkaline increased—Docetaxel—head and neck cancer	0.00159	0.00333	CcSEcCtD
Rivastigmine—Haemoglobin—Hydroxyurea—head and neck cancer	0.00155	0.00324	CcSEcCtD
Rivastigmine—Influenza like illness—Docetaxel—head and neck cancer	0.00155	0.00324	CcSEcCtD
Rivastigmine—Haemorrhage—Hydroxyurea—head and neck cancer	0.00154	0.00322	CcSEcCtD
Rivastigmine—Hallucination—Hydroxyurea—head and neck cancer	0.00153	0.00321	CcSEcCtD
Rivastigmine—Colitis—Docetaxel—head and neck cancer	0.00153	0.0032	CcSEcCtD
Rivastigmine—Cardiac arrest—Fluorouracil—head and neck cancer	0.00152	0.00319	CcSEcCtD
Rivastigmine—Skin exfoliation—Docetaxel—head and neck cancer	0.00152	0.00318	CcSEcCtD
Rivastigmine—Candida infection—Docetaxel—head and neck cancer	0.00152	0.00318	CcSEcCtD
Rivastigmine—Fluid retention—Docetaxel—head and neck cancer	0.00151	0.00317	CcSEcCtD
Rivastigmine—Ataxia—Fluorouracil—head and neck cancer	0.00151	0.00315	CcSEcCtD
Rivastigmine—Neuropathy—Docetaxel—head and neck cancer	0.00149	0.00313	CcSEcCtD
Rivastigmine—Alopecia—Vinblastine—head and neck cancer	0.00149	0.00312	CcSEcCtD
Rivastigmine—Dry skin—Fluorouracil—head and neck cancer	0.00147	0.00307	CcSEcCtD
Rivastigmine—Oesophagitis—Docetaxel—head and neck cancer	0.00145	0.00305	CcSEcCtD
Rivastigmine—Neoplasm—Docetaxel—head and neck cancer	0.00144	0.00301	CcSEcCtD
Rivastigmine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00143	0.003	CcSEcCtD
Rivastigmine—Pulmonary oedema—Docetaxel—head and neck cancer	0.00142	0.00297	CcSEcCtD
Rivastigmine—Muscular weakness—Fluorouracil—head and neck cancer	0.00141	0.00296	CcSEcCtD
Rivastigmine—Angiopathy—Hydroxyurea—head and neck cancer	0.0014	0.00292	CcSEcCtD
Rivastigmine—Dysphagia—Fluorouracil—head and neck cancer	0.00138	0.0029	CcSEcCtD
Rivastigmine—Sepsis—Docetaxel—head and neck cancer	0.00138	0.00289	CcSEcCtD
Rivastigmine—Chills—Hydroxyurea—head and neck cancer	0.00138	0.00289	CcSEcCtD
Rivastigmine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00136	0.00285	CcSEcCtD
Rivastigmine—Alopecia—Hydroxyurea—head and neck cancer	0.00136	0.00285	CcSEcCtD
Rivastigmine—Anaemia—Vinblastine—head and neck cancer	0.00136	0.00284	CcSEcCtD
Rivastigmine—Angina pectoris—Fluorouracil—head and neck cancer	0.00135	0.00282	CcSEcCtD
Rivastigmine—Phlebitis—Docetaxel—head and neck cancer	0.00134	0.00281	CcSEcCtD
Rivastigmine—Erythema—Hydroxyurea—head and neck cancer	0.00134	0.00281	CcSEcCtD
Rivastigmine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00133	0.0028	CcSEcCtD
Rivastigmine—Blood alkaline phosphatase increased—Docetaxel—head and neck cancer	0.00133	0.00278	CcSEcCtD
Rivastigmine—Malaise—Vinblastine—head and neck cancer	0.00132	0.00277	CcSEcCtD
Rivastigmine—Vertigo—Vinblastine—head and neck cancer	0.00132	0.00276	CcSEcCtD
Rivastigmine—Deafness—Docetaxel—head and neck cancer	0.00129	0.00271	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00129	0.00269	CcSEcCtD
Rivastigmine—Convulsion—Vinblastine—head and neck cancer	0.00127	0.00267	CcSEcCtD
Rivastigmine—Hypertension—Vinblastine—head and neck cancer	0.00127	0.00266	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00126	0.00265	CcSEcCtD
Rivastigmine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00124	0.0026	CcSEcCtD
Rivastigmine—Pneumonia—Fluorouracil—head and neck cancer	0.00124	0.0026	CcSEcCtD
Rivastigmine—Anaemia—Hydroxyurea—head and neck cancer	0.00124	0.00259	CcSEcCtD
Rivastigmine—Discomfort—Vinblastine—head and neck cancer	0.00124	0.00259	CcSEcCtD
Rivastigmine—Hot flush—Docetaxel—head and neck cancer	0.00124	0.00259	CcSEcCtD
Rivastigmine—Infestation NOS—Fluorouracil—head and neck cancer	0.00123	0.00258	CcSEcCtD
Rivastigmine—Infestation—Fluorouracil—head and neck cancer	0.00123	0.00258	CcSEcCtD
Rivastigmine—Menopausal symptoms—Docetaxel—head and neck cancer	0.00122	0.00257	CcSEcCtD
Rivastigmine—Atrial fibrillation—Docetaxel—head and neck cancer	0.00122	0.00255	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00122	0.00255	CcSEcCtD
Rivastigmine—Renal impairment—Docetaxel—head and neck cancer	0.00121	0.00254	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00121	0.00253	CcSEcCtD
Rivastigmine—Myocardial infarction—Fluorouracil—head and neck cancer	0.00121	0.00253	CcSEcCtD
Rivastigmine—Dermatitis bullous—Docetaxel—head and neck cancer	0.00121	0.00253	CcSEcCtD
Rivastigmine—Malaise—Hydroxyurea—head and neck cancer	0.00121	0.00253	CcSEcCtD
Rivastigmine—Conjunctivitis—Fluorouracil—head and neck cancer	0.0012	0.00251	CcSEcCtD
Rivastigmine—Urinary tract infection—Fluorouracil—head and neck cancer	0.0012	0.00251	CcSEcCtD
Rivastigmine—Cardiac failure—Docetaxel—head and neck cancer	0.00118	0.00248	CcSEcCtD
Rivastigmine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00117	0.00246	CcSEcCtD
Rivastigmine—Epistaxis—Fluorouracil—head and neck cancer	0.00116	0.00244	CcSEcCtD
Rivastigmine—Convulsion—Hydroxyurea—head and neck cancer	0.00116	0.00243	CcSEcCtD
Rivastigmine—Hyponatraemia—Docetaxel—head and neck cancer	0.00116	0.00243	CcSEcCtD
Rivastigmine—Sinusitis—Fluorouracil—head and neck cancer	0.00116	0.00242	CcSEcCtD
Rivastigmine—Pain in extremity—Docetaxel—head and neck cancer	0.00116	0.00242	CcSEcCtD
Rivastigmine—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00116	0.00242	CcSEcCtD
Rivastigmine—Anorexia—Vinblastine—head and neck cancer	0.00114	0.00239	CcSEcCtD
Rivastigmine—Migraine—Docetaxel—head and neck cancer	0.00114	0.00238	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00113	0.00237	CcSEcCtD
Rivastigmine—Discomfort—Hydroxyurea—head and neck cancer	0.00113	0.00236	CcSEcCtD
Rivastigmine—Haemoglobin—Fluorouracil—head and neck cancer	0.00111	0.00233	CcSEcCtD
Rivastigmine—Rhinitis—Fluorouracil—head and neck cancer	0.00111	0.00233	CcSEcCtD
Rivastigmine—Haemorrhage—Fluorouracil—head and neck cancer	0.00111	0.00232	CcSEcCtD
Rivastigmine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.0011	0.00231	CcSEcCtD
Rivastigmine—Pharyngitis—Fluorouracil—head and neck cancer	0.0011	0.0023	CcSEcCtD
Rivastigmine—Oedema—Hydroxyurea—head and neck cancer	0.00109	0.00229	CcSEcCtD
Rivastigmine—Ataxia—Docetaxel—head and neck cancer	0.00109	0.00228	CcSEcCtD
Rivastigmine—Infection—Hydroxyurea—head and neck cancer	0.00109	0.00228	CcSEcCtD
Rivastigmine—Paraesthesia—Vinblastine—head and neck cancer	0.00108	0.00225	CcSEcCtD
Rivastigmine—Dehydration—Docetaxel—head and neck cancer	0.00107	0.00225	CcSEcCtD
Rivastigmine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00107	0.00225	CcSEcCtD
Rivastigmine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00107	0.00224	CcSEcCtD
Rivastigmine—Liver function test abnormal—Docetaxel—head and neck cancer	0.00107	0.00223	CcSEcCtD
Rivastigmine—Skin disorder—Hydroxyurea—head and neck cancer	0.00106	0.00222	CcSEcCtD
Rivastigmine—Dry skin—Docetaxel—head and neck cancer	0.00106	0.00222	CcSEcCtD
Rivastigmine—Abdominal pain upper—Docetaxel—head and neck cancer	0.00106	0.00221	CcSEcCtD
Rivastigmine—Orthostatic hypotension—Docetaxel—head and neck cancer	0.00106	0.00221	CcSEcCtD
Rivastigmine—Breast disorder—Docetaxel—head and neck cancer	0.00104	0.00219	CcSEcCtD
Rivastigmine—Anorexia—Hydroxyurea—head and neck cancer	0.00104	0.00218	CcSEcCtD
Rivastigmine—Decreased appetite—Vinblastine—head and neck cancer	0.00104	0.00218	CcSEcCtD
Rivastigmine—Cramp muscle—Docetaxel—head and neck cancer	0.00104	0.00218	CcSEcCtD
Rivastigmine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00103	0.00216	CcSEcCtD
Rivastigmine—Constipation—Vinblastine—head and neck cancer	0.00102	0.00215	CcSEcCtD
Rivastigmine—Pain—Vinblastine—head and neck cancer	0.00102	0.00215	CcSEcCtD
Rivastigmine—Dysphagia—Docetaxel—head and neck cancer	0.000999	0.00209	CcSEcCtD
Rivastigmine—Arrhythmia—Fluorouracil—head and neck cancer	0.000989	0.00207	CcSEcCtD
Rivastigmine—Feeling abnormal—Vinblastine—head and neck cancer	0.000988	0.00207	CcSEcCtD
Rivastigmine—Bronchospasm—Docetaxel—head and neck cancer	0.000982	0.00206	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00098	0.00205	CcSEcCtD
Rivastigmine—Alopecia—Fluorouracil—head and neck cancer	0.000979	0.00205	CcSEcCtD
Rivastigmine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000974	0.00204	CcSEcCtD
Rivastigmine—Angina pectoris—Docetaxel—head and neck cancer	0.000973	0.00204	CcSEcCtD
Rivastigmine—Somnolence—Hydroxyurea—head and neck cancer	0.000972	0.00204	CcSEcCtD
Rivastigmine—Erythema—Fluorouracil—head and neck cancer	0.000964	0.00202	CcSEcCtD
Rivastigmine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000962	0.00202	CcSEcCtD
Rivastigmine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00095	0.00199	CcSEcCtD
Rivastigmine—Abdominal pain—Vinblastine—head and neck cancer	0.000947	0.00199	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000944	0.00198	CcSEcCtD
Rivastigmine—Fatigue—Hydroxyurea—head and neck cancer	0.000942	0.00197	CcSEcCtD
Rivastigmine—Constipation—Hydroxyurea—head and neck cancer	0.000935	0.00196	CcSEcCtD
Rivastigmine—Pain—Hydroxyurea—head and neck cancer	0.000935	0.00196	CcSEcCtD
Rivastigmine—Weight increased—Docetaxel—head and neck cancer	0.000909	0.0019	CcSEcCtD
Rivastigmine—Vision blurred—Fluorouracil—head and neck cancer	0.000908	0.0019	CcSEcCtD
Rivastigmine—Weight decreased—Docetaxel—head and neck cancer	0.000903	0.00189	CcSEcCtD
Rivastigmine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000901	0.00189	CcSEcCtD
Rivastigmine—Pneumonia—Docetaxel—head and neck cancer	0.000896	0.00188	CcSEcCtD
Rivastigmine—Anaemia—Fluorouracil—head and neck cancer	0.000891	0.00187	CcSEcCtD
Rivastigmine—Infestation NOS—Docetaxel—head and neck cancer	0.00089	0.00187	CcSEcCtD
Rivastigmine—Infestation—Docetaxel—head and neck cancer	0.00089	0.00187	CcSEcCtD
Rivastigmine—Hypersensitivity—Vinblastine—head and neck cancer	0.000883	0.00185	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000883	0.00185	CcSEcCtD
Rivastigmine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000878	0.00184	CcSEcCtD
Rivastigmine—Renal failure—Docetaxel—head and neck cancer	0.000875	0.00183	CcSEcCtD
Rivastigmine—Myocardial infarction—Docetaxel—head and neck cancer	0.000873	0.00183	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000873	0.00183	CcSEcCtD
Rivastigmine—Conjunctivitis—Docetaxel—head and neck cancer	0.000865	0.00181	CcSEcCtD
Rivastigmine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000864	0.00181	CcSEcCtD
Rivastigmine—Asthenia—Vinblastine—head and neck cancer	0.00086	0.0018	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000842	0.00176	CcSEcCtD
Rivastigmine—Epistaxis—Docetaxel—head and neck cancer	0.00084	0.00176	CcSEcCtD
Rivastigmine—Convulsion—Fluorouracil—head and neck cancer	0.000835	0.00175	CcSEcCtD
Rivastigmine—Chest pain—Fluorouracil—head and neck cancer	0.000821	0.00172	CcSEcCtD
Rivastigmine—Myalgia—Fluorouracil—head and neck cancer	0.000821	0.00172	CcSEcCtD
Rivastigmine—Diarrhoea—Vinblastine—head and neck cancer	0.00082	0.00172	CcSEcCtD
Rivastigmine—Discomfort—Fluorouracil—head and neck cancer	0.000811	0.0017	CcSEcCtD
Rivastigmine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000805	0.00169	CcSEcCtD
Rivastigmine—Haemoglobin—Docetaxel—head and neck cancer	0.000803	0.00168	CcSEcCtD
Rivastigmine—Rhinitis—Docetaxel—head and neck cancer	0.000801	0.00168	CcSEcCtD
Rivastigmine—Haemorrhage—Docetaxel—head and neck cancer	0.000799	0.00167	CcSEcCtD
Rivastigmine—Hepatitis—Docetaxel—head and neck cancer	0.000799	0.00167	CcSEcCtD
Rivastigmine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000795	0.00167	CcSEcCtD
Rivastigmine—Confusional state—Fluorouracil—head and neck cancer	0.000793	0.00166	CcSEcCtD
Rivastigmine—Pharyngitis—Docetaxel—head and neck cancer	0.000793	0.00166	CcSEcCtD
Rivastigmine—Dizziness—Vinblastine—head and neck cancer	0.000793	0.00166	CcSEcCtD
Rivastigmine—Urinary tract disorder—Docetaxel—head and neck cancer	0.000789	0.00165	CcSEcCtD
Rivastigmine—Oedema peripheral—Docetaxel—head and neck cancer	0.000787	0.00165	CcSEcCtD
Rivastigmine—Oedema—Fluorouracil—head and neck cancer	0.000787	0.00165	CcSEcCtD
Rivastigmine—Connective tissue disorder—Docetaxel—head and neck cancer	0.000785	0.00165	CcSEcCtD
Rivastigmine—Asthenia—Hydroxyurea—head and neck cancer	0.000784	0.00164	CcSEcCtD
Rivastigmine—Urethral disorder—Docetaxel—head and neck cancer	0.000783	0.00164	CcSEcCtD
Rivastigmine—Infection—Fluorouracil—head and neck cancer	0.000782	0.00164	CcSEcCtD
Rivastigmine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000772	0.00162	CcSEcCtD
Rivastigmine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00077	0.00161	CcSEcCtD
Rivastigmine—Visual impairment—Docetaxel—head and neck cancer	0.00077	0.00161	CcSEcCtD
Rivastigmine—Tachycardia—Fluorouracil—head and neck cancer	0.000768	0.00161	CcSEcCtD
Rivastigmine—Vomiting—Vinblastine—head and neck cancer	0.000762	0.0016	CcSEcCtD
Rivastigmine—Erythema multiforme—Docetaxel—head and neck cancer	0.000756	0.00158	CcSEcCtD
Rivastigmine—Headache—Vinblastine—head and neck cancer	0.000751	0.00157	CcSEcCtD
Rivastigmine—Anorexia—Fluorouracil—head and neck cancer	0.00075	0.00157	CcSEcCtD
Rivastigmine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000748	0.00157	CcSEcCtD
Rivastigmine—Eye disorder—Docetaxel—head and neck cancer	0.000747	0.00156	CcSEcCtD
Rivastigmine—Flushing—Docetaxel—head and neck cancer	0.000742	0.00155	CcSEcCtD
Rivastigmine—Cardiac disorder—Docetaxel—head and neck cancer	0.000742	0.00155	CcSEcCtD
Rivastigmine—Hypotension—Fluorouracil—head and neck cancer	0.000735	0.00154	CcSEcCtD
Rivastigmine—Angiopathy—Docetaxel—head and neck cancer	0.000725	0.00152	CcSEcCtD
Rivastigmine—Dizziness—Hydroxyurea—head and neck cancer	0.000723	0.00151	CcSEcCtD
Rivastigmine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00072	0.00151	CcSEcCtD
Rivastigmine—Chills—Docetaxel—head and neck cancer	0.000717	0.0015	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000717	0.0015	CcSEcCtD
Rivastigmine—Arrhythmia—Docetaxel—head and neck cancer	0.000714	0.0015	CcSEcCtD
Rivastigmine—Nausea—Vinblastine—head and neck cancer	0.000712	0.00149	CcSEcCtD
Rivastigmine—Insomnia—Fluorouracil—head and neck cancer	0.000712	0.00149	CcSEcCtD
Rivastigmine—Paraesthesia—Fluorouracil—head and neck cancer	0.000706	0.00148	CcSEcCtD
Rivastigmine—Alopecia—Docetaxel—head and neck cancer	0.000706	0.00148	CcSEcCtD
Rivastigmine—Dyspnoea—Fluorouracil—head and neck cancer	0.000701	0.00147	CcSEcCtD
Rivastigmine—Mental disorder—Docetaxel—head and neck cancer	0.0007	0.00147	CcSEcCtD
Rivastigmine—Somnolence—Fluorouracil—head and neck cancer	0.000699	0.00147	CcSEcCtD
Rivastigmine—Malnutrition—Docetaxel—head and neck cancer	0.000696	0.00146	CcSEcCtD
Rivastigmine—Erythema—Docetaxel—head and neck cancer	0.000696	0.00146	CcSEcCtD
Rivastigmine—Vomiting—Hydroxyurea—head and neck cancer	0.000695	0.00146	CcSEcCtD
Rivastigmine—Dyspepsia—Fluorouracil—head and neck cancer	0.000693	0.00145	CcSEcCtD
Rivastigmine—Rash—Hydroxyurea—head and neck cancer	0.000689	0.00144	CcSEcCtD
Rivastigmine—Dermatitis—Hydroxyurea—head and neck cancer	0.000689	0.00144	CcSEcCtD
Rivastigmine—Headache—Hydroxyurea—head and neck cancer	0.000685	0.00143	CcSEcCtD
Rivastigmine—Decreased appetite—Fluorouracil—head and neck cancer	0.000684	0.00143	CcSEcCtD
Rivastigmine—Dysgeusia—Docetaxel—head and neck cancer	0.000681	0.00143	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000679	0.00142	CcSEcCtD
Rivastigmine—Back pain—Docetaxel—head and neck cancer	0.000673	0.00141	CcSEcCtD
Rivastigmine—Pain—Fluorouracil—head and neck cancer	0.000673	0.00141	CcSEcCtD
Rivastigmine—Muscle spasms—Docetaxel—head and neck cancer	0.000669	0.0014	CcSEcCtD
Rivastigmine—Nausea—Hydroxyurea—head and neck cancer	0.000649	0.00136	CcSEcCtD
Rivastigmine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000648	0.00136	CcSEcCtD
Rivastigmine—Anaemia—Docetaxel—head and neck cancer	0.000643	0.00135	CcSEcCtD
Rivastigmine—Urticaria—Fluorouracil—head and neck cancer	0.000625	0.00131	CcSEcCtD
Rivastigmine—Syncope—Docetaxel—head and neck cancer	0.000624	0.00131	CcSEcCtD
Rivastigmine—Body temperature increased—Fluorouracil—head and neck cancer	0.000622	0.0013	CcSEcCtD
Rivastigmine—Palpitations—Docetaxel—head and neck cancer	0.000615	0.00129	CcSEcCtD
Rivastigmine—Loss of consciousness—Docetaxel—head and neck cancer	0.000612	0.00128	CcSEcCtD
Rivastigmine—Cough—Docetaxel—head and neck cancer	0.000607	0.00127	CcSEcCtD
Rivastigmine—Convulsion—Docetaxel—head and neck cancer	0.000603	0.00126	CcSEcCtD
Rivastigmine—Hypertension—Docetaxel—head and neck cancer	0.000601	0.00126	CcSEcCtD
Rivastigmine—Arthralgia—Docetaxel—head and neck cancer	0.000592	0.00124	CcSEcCtD
Rivastigmine—Chest pain—Docetaxel—head and neck cancer	0.000592	0.00124	CcSEcCtD
Rivastigmine—Myalgia—Docetaxel—head and neck cancer	0.000592	0.00124	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000588	0.00123	CcSEcCtD
Rivastigmine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00058	0.00121	CcSEcCtD
Rivastigmine—Dry mouth—Docetaxel—head and neck cancer	0.000579	0.00121	CcSEcCtD
Rivastigmine—Confusional state—Docetaxel—head and neck cancer	0.000573	0.0012	CcSEcCtD
Rivastigmine—Oedema—Docetaxel—head and neck cancer	0.000568	0.00119	CcSEcCtD
Rivastigmine—Infection—Docetaxel—head and neck cancer	0.000564	0.00118	CcSEcCtD
Rivastigmine—Shock—Docetaxel—head and neck cancer	0.000559	0.00117	CcSEcCtD
Rivastigmine—Nervous system disorder—Docetaxel—head and neck cancer	0.000557	0.00117	CcSEcCtD
Rivastigmine—Pruritus—Fluorouracil—head and neck cancer	0.000557	0.00117	CcSEcCtD
Rivastigmine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000556	0.00116	CcSEcCtD
Rivastigmine—Tachycardia—Docetaxel—head and neck cancer	0.000554	0.00116	CcSEcCtD
Rivastigmine—Skin disorder—Docetaxel—head and neck cancer	0.000552	0.00116	CcSEcCtD
Rivastigmine—Anorexia—Docetaxel—head and neck cancer	0.000541	0.00113	CcSEcCtD
Rivastigmine—Diarrhoea—Fluorouracil—head and neck cancer	0.000538	0.00113	CcSEcCtD
Rivastigmine—Hypotension—Docetaxel—head and neck cancer	0.000531	0.00111	CcSEcCtD
Rivastigmine—Dizziness—Fluorouracil—head and neck cancer	0.00052	0.00109	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000517	0.00108	CcSEcCtD
Rivastigmine—Insomnia—Docetaxel—head and neck cancer	0.000514	0.00108	CcSEcCtD
Rivastigmine—Paraesthesia—Docetaxel—head and neck cancer	0.00051	0.00107	CcSEcCtD
Rivastigmine—Dyspnoea—Docetaxel—head and neck cancer	0.000506	0.00106	CcSEcCtD
Rivastigmine—Somnolence—Docetaxel—head and neck cancer	0.000505	0.00106	CcSEcCtD
Rivastigmine—Vomiting—Fluorouracil—head and neck cancer	0.0005	0.00105	CcSEcCtD
Rivastigmine—Dyspepsia—Docetaxel—head and neck cancer	0.0005	0.00105	CcSEcCtD
Rivastigmine—Rash—Fluorouracil—head and neck cancer	0.000496	0.00104	CcSEcCtD
Rivastigmine—Dermatitis—Fluorouracil—head and neck cancer	0.000496	0.00104	CcSEcCtD
Rivastigmine—Decreased appetite—Docetaxel—head and neck cancer	0.000494	0.00103	CcSEcCtD
Rivastigmine—Headache—Fluorouracil—head and neck cancer	0.000493	0.00103	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.00049	0.00103	CcSEcCtD
Rivastigmine—Fatigue—Docetaxel—head and neck cancer	0.00049	0.00103	CcSEcCtD
Rivastigmine—Pain—Docetaxel—head and neck cancer	0.000486	0.00102	CcSEcCtD
Rivastigmine—Constipation—Docetaxel—head and neck cancer	0.000486	0.00102	CcSEcCtD
Rivastigmine—Feeling abnormal—Docetaxel—head and neck cancer	0.000468	0.00098	CcSEcCtD
Rivastigmine—Nausea—Fluorouracil—head and neck cancer	0.000467	0.000979	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000464	0.000973	CcSEcCtD
Rivastigmine—Body temperature increased—Docetaxel—head and neck cancer	0.000449	0.000941	CcSEcCtD
Rivastigmine—Abdominal pain—Docetaxel—head and neck cancer	0.000449	0.000941	CcSEcCtD
Rivastigmine—Hypersensitivity—Docetaxel—head and neck cancer	0.000418	0.000877	CcSEcCtD
Rivastigmine—Asthenia—Docetaxel—head and neck cancer	0.000407	0.000854	CcSEcCtD
Rivastigmine—Pruritus—Docetaxel—head and neck cancer	0.000402	0.000842	CcSEcCtD
Rivastigmine—Diarrhoea—Docetaxel—head and neck cancer	0.000389	0.000814	CcSEcCtD
Rivastigmine—Dizziness—Docetaxel—head and neck cancer	0.000376	0.000787	CcSEcCtD
Rivastigmine—Vomiting—Docetaxel—head and neck cancer	0.000361	0.000756	CcSEcCtD
Rivastigmine—Rash—Docetaxel—head and neck cancer	0.000358	0.00075	CcSEcCtD
Rivastigmine—Dermatitis—Docetaxel—head and neck cancer	0.000358	0.000749	CcSEcCtD
Rivastigmine—Headache—Docetaxel—head and neck cancer	0.000356	0.000745	CcSEcCtD
Rivastigmine—Nausea—Docetaxel—head and neck cancer	0.000337	0.000707	CcSEcCtD
